UDI-001

N/A

Report date: 2022/08/29 20:00:24

Base Information

Drug NameUDI-001

Drug Alias NameUC-MSCsUDI-001UDI001

ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLeukomalacia, PeriventricularCerebral Palsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesRohto Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRohto Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsLeukomalacia, PeriventricularCerebral Palsy

Inactive IndicationsN/A

Other Information

ATC CodeN/A